Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia.
| Title | Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia. |
| Publication Type | Journal Article |
| Year of Publication | 2011 |
| Authors | Lazaraki, G., Akriviadis E., Pilpilidis I., Parisi I., Tzilves D., & Tarpangos A. |
| Journal | Am J Gastroenterol |
| Volume | 106 |
| Issue | 12 |
| Pagination | 2204-6 |
| Date Published | 2011 Dec |
| ISSN | 1572-0241 |
| Keywords | Aged, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Endoscopy, Gastrointestinal, Epistaxis, Female, Gastrointestinal Hemorrhage, Gastrointestinal Tract, Humans, Iron, Liver, Secondary Prevention, Telangiectasia, Hereditary Hemorrhagic, Tomography, X-Ray Computed, Treatment Outcome |
| DOI | 10.1038/ajg.2011.287 |
| Alternate Journal | Am. J. Gastroenterol. |
| PubMed ID | 22138950 |
